Dermatology · Boston, MA
NPI
1558422584
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
330 Brookline Ave
Boston, MA, 02215
Phone (617) 667-3753
Groups this clinician bills Medicare through
Medicare paid, 2024
$190K
3,288 services
Medicare patients, 2024
1,079
Average age 74
Drug cost, 2024
$2.6M
2,032 prescriptions
Company payments, 2023
$14
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farhana Jan was code 99213 (office e&m - established), 567 times for 506 patients. In total Farhana Jan billed 3,288 services in 52 codes, and Medicare paid $190K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 567 | 506 | $68.53 | $39K |
| 17003 Destruction Skin Lesion | Office | 483 | 154 | $5.42 | $2,619 |
| 99214 Office E&M - Established | Office | 301 | 266 | $96.95 | $29K |
| 17000 Destruction Skin Lesion | Office | 299 | 257 | $41.46 | $12K |
| 17110 Destruction Skin Lesion | Office | 251 | 228 | $91.09 | $23K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 174 | 168 | $13.21 | $2,299 |
| 17003 Destruction Skin Lesion | Facility | 145 | 38 | $1.61 | $234 |
| 99213 Office E&M - Established | Facility | 135 | 124 | $47.98 | $6,477 |
| 99214 Office E&M - Established | Facility | 104 | 96 | $72.35 | $7,525 |
| 11102 Skin Biopsy | Office | 90 | 84 | $70.80 | $6,372 |
| 17000 Destruction Skin Lesion | Facility | 79 | 68 | $34.98 | $2,764 |
| 17110 Destruction Skin Lesion | Facility | 67 | 63 | $55.30 | $3,705 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 51 | 48 | $13.82 | $705 |
| 17261 Destruction Skin Lesion | Office | 49 | 43 | $116.51 | $5,709 |
| 96567 Skin | Office | 43 | 43 | $109.38 | $4,703 |
By year: 2022 $169K for 3,038 services; 2023 $174K for 3,055 services; 2024 $190K for 3,288 services.
Medicare prescription drug claims, 2024
In 2024, the drug Farhana Jan prescribed most often to Medicare patients was Dupixent Pen (Dupilumab), with 220 prescriptions and refills. In total Farhana Jan wrote 2,032 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Pen Dupilumab | 220 | 220 | 26 | $933K |
| Triamcinolone Acetonide Generic | 147 | 163 | 95 | $1,662 |
| Ketoconazole Generic | 140 | 161 | 60 | $2,044 |
| Minoxidil Generic | 118 | 331 | 44 | $1,640 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 104 | 110 | 72 | $4,251 |
| Fluorouracil Generic | 97 | 99 | 81 | $5,973 |
| Doxycycline Hyclate Generic | 80 | 139 | 22 | $2,040 |
| Tretinoin Generic | 77 | 87 | 23 | $4,062 |
| Tacrolimus Generic | 70 | 74 | 46 | $7,862 |
| Clindamycin Phosphate Generic | 62 | 70 | 23 | $2,016 |
| Clobetasol Propionate Generic | 57 | 74 | 35 | $3,434 |
| Dupixent Syringe Dupilumab | 55 | 56 | Under 11 | $205K |
| Valacyclovir Valacyclovir Hcl | 47 | 69 | 20 | $1,006 |
| Opzelura Ruxolitinib Phosphate | 38 | 40 | 14 | $112K |
| Finasteride Generic | 37 | 101 | 13 | $756 |
Brand drugs: 556 claims; generic drugs: 1,476 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Farhana Jan $14 ($14 in general payments such as food, travel and fees) from 1 company. The largest payer was Dermavant Sciences, Inc. with $14.
| Company | Payments | Amount |
|---|---|---|
| Dermavant Sciences, Inc. | 1 | $14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.